Edward Chern

Prof. Edward Chern

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2015 in Stem Cell Reports
Verified
Journal Article
Open access
TKTaketomo Kido
Taketomo Kido
YKYuta Koui
Yuta Koui
KSKaori Suzuki
Kaori Suzuki
AKAyaka Kobayashi
Ayaka Kobayashi
YMYasushi Miura
Yasushi Miura
AMAtsushi Miyajima
Atsushi Miyajima
To develop a culture system for large-scale production of mature hepatocytes, liver progenitor cells (LPCs) with a high proliferation potential would be advantageous. We have found that carboxypeptidase M (CPM) is highly expressed in embryonic LPCs, hepatoblasts, while its expression is decreased along with hepatic maturation. Consistently, CPM expression was transiently induced during hepatic specification from human-induced pluripotent stem cells (hiPSCs). CPM(+) cells isolated from differentiated hiPSCs at the immature hepatocyte stage proliferated extensively in vitro and expressed a set of genes that were typical of hepatoblasts. Moreover, the CPM(+) cells exhibited a mature hepatocyte phenotype after induction of hepatic maturation and also underwent cholangiocytic differentiation in a three-dimensional culture system. These results indicated that hiPSC-derived CPM(+) cells share the characteristics of LPCs, with the potential to proliferate and differentiate bi-directionally. Thus, CPM is a useful marker for isolating hiPSC-derived LPCs, which allows development of a large-scale culture system for producing hepatocytes and cholangiocytes.

1 January 2021 in Biomaterials
Verified
Journal Article
Closed access
PCPo-Hsiang Chang
Po-Hsiang Chang
HCHsiao-Mei Chao
Hsiao-Mei Chao
ECEdward Chern
Edward Chern
Shan-hui HsuShan-hui Hsu
Shan-hui Hsu

3 April 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
PCPo-Hsiang Chang
Po-Hsiang Chang
KSKeisuke Sekine
Keisuke Sekine
HCHsiao-Mei Chao
Hsiao-Mei Chao
Shan-hui HsuShan-hui Hsu
Shan-hui Hsu
ECEdward Chern
Edward Chern
Cancer stem cells (CSCs), a small population of cancer cells, have been considered to be the origin of cancer initiation, recurrence, and metastasis. Tumor microenvironment provides crucial signals for CSCs to maintain stem cell properties and promotes tumorigenesis. Therefore, establishment of an appropriate cell culture system to mimic the microenvironment for CSC studies is an important issue. In this study, we grew colon and hepatocellular carcinoma (HCC) cells on chitosan membranes and evaluated the tumor progression and the CSC properties. Experimental results showed that culturing cancer cells on chitosan increased cell motility, drug resistance, quiescent population, self-renewal capacity, and the expression levels of stemness and CSC marker genes, such as OCT4, NANOG, CD133, CD44, and EpCAM. Furthermore, we demonstrated that chitosan might activate canonical Wnt/β-catenin-CD44 axis signaling in CD44positive colon cancer cells and noncanonical Wnt-STAT3 signaling in CD44negative HCC cells. In conclusion, chitosan as culture substrates activated the essential signaling of CSCs and promoted CSC properties. The chitosan culture system provides a convenient platform for the research of CSC biology and screening of anticancer drugs.

1 December 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
HCHsiao-Mei Chao
Hsiao-Mei Chao
HHHong-Xuan Huang
Hong-Xuan Huang
PCPo-Hsiang Chang
Po-Hsiang Chang
KTKuo-Chang Tseng
Kuo-Chang Tseng
AMAtsushi Miyajima
Atsushi Miyajima
ECEdward Chern
Edward Chern
Y-box binding protein-1 promotes hepatocellular carcinoma-initiating cell progression and tumorigenesis via Wnt/β-catenin pathway

1 December 2020 in Cancer Research
Verified
Journal Article
Closed access
PDF file
TWTeh-Wei Wang
Teh-Wei Wang
ECEdward Chern
Edward Chern
CHChao-Wei Hsu
Chao-Wei Hsu
KTKuo-Chang Tseng
Kuo-Chang Tseng
HCHsiao-Mei Chao
Hsiao-Mei Chao
NAD-dependent deacetylase sirtuin-1 (SIRT1) is a class III histone deacetylase that positively regulates cancer-related pathways such as proliferation and stress resistance. SIRT1 has been shown to promote progression of colorectal cancer and is associated with cancer stemness, yet the precise mechanism between colorectal cancer stemness and SIRT1 remains to be further clarified. Here we report that SIRT1 signaling regulates colorectal cancer stemness by enhancing expression of CD24, a colorectal cancer stemness promoter. A novel miRNA, miR-1185-1, suppressed the expression of CD24 by targeting its 3′UTR (untranslated region) and could be inhibited by SIRT1 via histone deacetylation. Targeting SIRT1 by RNAi led to elevated H3 lysine 9 acetylation on the promoter region of miR-1185-1, which increased expression of miR-1185-1 and further repressed CD24 translation and colorectal cancer stemness. In a mouse xenograft model, overexpression of miR-1185-1 in colorectal cancer cells substantially reduced tumor growth. In addition, expression of miR-1185-1 was downregulated in human colorectal cancer tissues, whereas expression of CD24 was increased. In conclusion, this study not only demonstrates the essential roles of a SIRT1–miR-1185-1–CD24 axis in both colorectal cancer stemness properties and tumorigenesis but provides a potential therapeutic target for colorectal cancer treatment. Significance: A novel tumor suppressor miR-1185-1 is involved in molecular regulation of CD24- and SIRT1-related cancer stemness networks, marking it a potential therapeutic target in colorectal cancer.

19 August 2022 in Frontiers in Microbiology
Verified
Journal Article
Open access
MCMing-Cheng Chiang
Ming-Cheng Chiang
ECEdward Chern
Edward Chern
Recently, increasing studies have emphasized the importance of commensal bacteria in humans, including microbiota in the oral cavity, gut, vagina, or skin. Ocular surface microbiota (OSM) is gaining great importance as new methodologies for bacteria DNA sequencing have been published. This review outlines the current understanding and investigation of OSM and introduces the new concept of the gut–eye axis. Moreover, we have collected current studies that focus on the relationship between ophthalmic infectious disease and alterations in the OSM or human gut microbiota. Finally, we discuss the current application of probiotics in ophthalmic infectious disease, its limitations to date, and futural directions.